Arp2/3複合体の小分子阻害剤の2つのクラスの特徴づけ
B J Nolen1, N Tomasevic, A Russell
1Department of Molecular Cellular and Developmental Biology, Yale University, New Haven, Connecticut 06520, USA.
Nature
|August 4, 2009
まとめ
研究者らは,細胞運動に不可欠なアクチン関連タンパク質 (Arp) 2/3複合体を標的とした2つの小分子阻害剤を開発した. これらの化合物は,Arp2/3複合体の機能を研究する新しい方法を生体細胞に提供します.
科学分野:
- 細胞生物学 細胞生物学
- バイオケミストリー バイオケミストリー
背景:
- Arp2/3複合体によって調節されるアクチンフィラメントポリメリゼーションは,細胞の運動性を駆動する.
- ニューロンの成長コンの誘導およびその他のプロセスにおけるArp2/3の複雑な役割の理解は,生細胞研究における可逆性阻害剤の欠如によって制限されています.
研究 の 目的:
- 生体細胞におけるArp2/3複合媒介アクチン核形成を逆転的に阻害する新しい小分子を開発し,特徴づけること.
主な方法:
- Arp2/3複合体を標的にする小分子のスクリーニングと特徴付け.
- アクチンフィラメント核形成の抑制を評価するための生化学的測定法.
- Listeria彗星尾の形成とモノサイトポドソームの組み立ての抑制を調査する細胞ベースの測定法.
主要な成果:
- Arp2/3複合体の異なる部位に結合する2種類の小分子阻害剤 (CK-0944636とCK-0993548) が特定されました.
- CK-0944636は,Arp2/3の形状の変化を阻害することによってArp2/3複合体の活動を抑制し,CK-0993548はArp3の形状変化を変化させます.
- 両方の阻害剤は,リステリアアクチン彗星尾と単細胞ポドソームを含む,Arp2/3複合体に依存するアクチン構造を効果的に抑制しました.
結論:
- 新しい小分子は,活体細胞におけるArp2/3複合体の機能の可逆的抑制と研究のための強力なツールを提供します.
- これらの阻害剤は,Arp2/3複合体媒介アクチン核化の多様な細胞プロセスに対する特定の貢献に関する研究を促進します.
関連する概念動画
Generation of Straight or Branched Actin Filaments
2.9K
The straight or branched structure formation of actin filaments is controlled by nucleating proteins such as the formins and Arp2/3 complex. Formin-mediated assembly results in straight filaments, whereas Arp2/3 protein complex-mediated assembly results in branched actin filaments.
Arp2/3 Complex
Arp2/3 complex is a seven-subunit complex consisting of two proteins similar to actin- Arp2 and Arp3, and five other subunits that help keep Arp2 and Arp3 inactive. When required, the complex is...
Arp2/3 Complex
Arp2/3 complex is a seven-subunit complex consisting of two proteins similar to actin- Arp2 and Arp3, and five other subunits that help keep Arp2 and Arp3 inactive. When required, the complex is...
2.9K
Actin Filament Depolymerization
3.0K
Actin filaments (F-actin) are composed of actin subunits. The dissociation of actin monomers can occur from either end of F-actin. The rate of dissociation is faster from the minus-end or the pointed end, where the actin subunits exist with a bound ADP, together known as ADP-actin. The depolymerization of F-actin is aided by proteins, including the actin-depolymerizing factor (ADF) and cofilin family of proteins, gelsolin, and glia maturation factor (GMF).
In F-actin, the ADF/cofilin proteins...
In F-actin, the ADF/cofilin proteins...
3.0K
GPCR Desensitization
6.1K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.1K
Combined Effects of Drugs: Antagonism
11.6K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.6K
The Two-State Receptor Model
3.5K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
3.5K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.1K
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
1.1K


